Artgen Biotech PJSC (MOEX: ISKJ)

Artgen Biotech PJSC Balance Sheet

Financials in millions RUB. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	370.13	544.94	201.66	193.29	107.39	89.75
Trading Asset Securities	24.79	27.39	25.4	0.51	0.51	88.57
Cash & Short-Term Investments	394.93	572.33	227.06	193.8	107.9	178.32
Cash Growth	7.58%	152.07%	17.16%	79.61%	-39.49%	-8.75%
Accounts Receivable	86.02	81.83	67.86	83.2	90.18	61.72
Other Receivables	66.43	72.58	61.69	23.92	41.98	23.29
Receivables	219.55	205.38	185.11	131.76	151.46	96.87
Inventory	251.89	226.31	223.87	245.79	233.54	172.67
Other Current Assets	148.9	113.22	53.74	86.71	83.04	61.79
Total Current Assets	1,015	1,117	689.77	658.06	575.93	509.65
Property, Plant & Equipment	369.46	315.87	280.51	285	330.25	379.32
Long-Term Investments	161.21	161.33	193.34	120.62	54.35	18.19
Other Intangible Assets	166.49	174.9	150.1	128.6	116.93	126.82
Long-Term Deferred Tax Assets	93.1	90.83	83.03	86.12	76.03	65.05
Long-Term Deferred Charges	654.39	631.35	586.62	414.09	342.11	293.04
Total Assets	2,508	2,544	2,045	1,737	1,512	1,399
Accounts Payable	28.01	53.41	33.87	35.94	35.38	41.06
Short-Term Debt	-	0.73	0.73	0.2	0.19	4.94
Current Portion of Long-Term Debt	172.34	219.72	106.44	-	177.77	133.44
Current Portion of Leases	25.17	19.53	11.69	8.89	9.91	7.98
Current Income Taxes Payable	17.34	24.84	24.57	14.61	10.7	4.88
Other Current Liabilities	296.71	243.16	218.28	312.52	322.18	295.15
Total Current Liabilities	539.57	561.4	395.57	372.15	556.13	487.46
Long-Term Debt	437.53	427.2	601.38	494.23	175	143.66
Long-Term Leases	154.56	119.77	111.36	113.82	125.59	134.19
Long-Term Deferred Tax Liabilities	-	-	-	-	-	0.32
Other Long-Term Liabilities	422.44	460.96	366	296.49	240.38	262.69
Total Liabilities	1,554	1,569	1,474	1,277	1,097	1,028
Common Stock	9.27	9.27	9.27	8.5	7.5	7.5
Additional Paid-In Capital	625.94	625.13	612.1	567.43	151.93	135
Retained Earnings	312.33	318.15	146.45	94.13	69.42	-9.97
Treasury Stock	-485.45	-421.99	-447.85	-446.98	-34.97	-22.06
Comprehensive Income & Other	-29.41	-30.06	21.07	11.7	0.38	0.38
Total Common Equity	432.67	500.49	341.04	234.78	194.26	110.85
Minority Interest	521.2	474.25	229.22	225.78	220.74	259.88
Shareholders' Equity	953.87	974.73	570.26	460.56	415	370.73
Total Liabilities & Equity	2,508	2,544	2,045	1,737	1,512	1,399
Total Debt	789.6	786.96	831.6	617.13	488.46	424.22
Net Cash (Debt)	-394.67	-214.62	-604.55	-423.33	-380.56	-245.9
Net Cash Per Share	-5.34	-2.32	-6.96	-5.29	-5.07	-3.28
Filing Date Shares Outstanding	73.92	75.15	81.61	85	75	75
Total Common Shares Outstanding	73.92	75.15	81.61	85	75	75
Working Capital	475.69	555.84	294.2	285.9	19.81	22.19
Book Value Per Share	5.85	6.66	4.18	2.76	2.59	1.48
Tangible Book Value	266.18	325.59	190.94	106.18	77.33	-15.97
Tangible Book Value Per Share	3.60	4.33	2.34	1.25	1.03	-0.21
Buildings	78.55	67.06	49.65	97.89	94.08	95.41
Machinery	392.94	375.42	353.72	336.45	325.07	315.51
Construction In Progress	-	-	-	0.05	0.9	-

Source: S&P Capital IQ. Standard template. Financial Sources.